Merck Awarded its First CRISPR Patent by Australian Patent Office – Labmate Online
|
Merck Awarded its First CRISPR Patent by Australian Patent Office
Labmate Online The patent is the first that Merck has received for CRISPR technology. The patent covers chromosomal integration, or cutting of the chromosomal sequence of eukaryotic cells (such as mammalian and plant cells) and insertion of an external or donor DNA … |
